Related references
Note: Only part of the references are listed.HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications
J. A. Villella et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Use of trastuzumab in the treatment of metastatic endometrial cancer
E Jewell et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Clinical significance of Her-2/neu overexpression in uterine serous carcinoma
TP Diaz-Montes et al.
GYNECOLOGIC ONCOLOGY (2006)
Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer
AD Santin et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
